Log in
Enquire now
‌

US Patent 10925264 Genetically modified non-human animal with human or chimeric LAG-3

Patent 10925264 was granted and assigned to Biocytogen on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The present disclosure relates to the genetically modified non-human animals that express a human or chimeric (e.g., humanized) Lymphocyte Activation Gene 3 (LAG-3), and methods of use thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10925264 Genetically modified non-human animal with human or chimeric LAG-3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.